MedTrace Logo

Évaluation de l'Impact du Compressed Sensing Sur le Signal QSM

NCT04907487 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 82

Last updated 2026-01-05

No results posted yet for this study

Summary

Patients who have agreed to participate in the study will complete the MRI protocol as part of routine care, to which a maximum of four additional 25-minute sequences will be added.

MRI of routine care includes at least the following sequences:

* 3D T1 TFE (2 minutes)
* T2 TSE (2 minutes)
* 3D FLAIR (3 minutes)

The sequences added by the research lasting 25 minutes are:

* SWI QSM 1.0iso 8 echoes (10 minutes)
* SWI QSM 1.0iso 8 echoes CS 6 (7 minutes)
* SWI QSM 1.0iso 8 echoes CS 9 (5 minutes)
* SWI QSM 1.0iso 8 echoes CS 12 (3 minutes)

Conditions

  • MRI

Interventions

DEVICE

MRI

MRI of routine care includes at least the following sequences: * 3D T1 TFE (2 minutes) * T2 TSE (2 minutes) * 3D FLAIR (3 minutes) The sequences added by the research lasting 25 minutes are: * SWI QSM 1.0iso 8 echoes (10 minutes) * SWI QSM 1.0iso 8 echoes CS 6 (7 minutes) * SWI QSM 1.0iso 8 echoes CS 9 (5 minutes) * SWI QSM 1.0iso 8 echoes CS 12 (3 minutes)

Sponsors & Collaborators

  • Fondation Ophtalmologique Adolphe de Rothschild

    lead NETWORK

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-15
Primary Completion
2025-05-14
Completion
2025-05-14

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04907487 on ClinicalTrials.gov